Immunotherapy Following Chemotherapy May Benefit Metastatic Ovarian Cancer Patients

Immunotherapy Following Chemotherapy May Benefit Metastatic Ovarian Cancer Patients
Women with metastatic ovarian cancer treated with chemotherapy prior to surgery have higher levels of specific immune cells with the ability to attack tumor cells. These findings suggest that immunotherapy designed to remove the breaks of immune cells may be used in these patients to enhance anti-tumor responses and improve disease control. The study, titled “Neoadjuvant Chemotherapy Modulates the Immune

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *